Facebook Wants to Give Users Control of the Ads They See
Facebook says it wants users to have more privacy, and one way to do that is to allow them to control the ads they see.
Erin Egan, the company’s Chief Privacy Officer and VP of U.S. Public Policy, says it’s part of the social media giant’s goal to improve the user experience.
“People choose to come to Facebook. They choose to engage with communities, with issues, with lots of folks that matter to them, and so what we want to do is make that experience meaningful for people,” she told Cheddar in an interview Tuesday. “Ads [are] one piece of it. We want advertising to be useful, we want the experience to be meaningful. That’s what this is all about.”
Facebook has come under fire for the way ads appear on its site -- both because publishers could target users based on race, religion, or other factors and because of the way Russian-backed groups used the platform during the 2016 election.
Earlier this week the CMO of Unilever threatened to pull its ads from both Facebook and Google if the companies didn’t clean up their acts.
For full interview [click here](https://cheddar.com/videos/the-importance-of-facebook-privacy-check-ups).
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
